Clovis Oncology CEO Patrick Mahaffy's 2020 pay falls 53% to $3.2M
Clovis Oncology reports 2020 executive compensation
By ExecPay News
Published: April 28, 2021
Clovis Oncology reported fiscal year 2020 executive compensation information on April 28, 2021.
In 2020, five executives at Clovis Oncology received on average a compensation package of $1.7M, a 55% decrease compared to previous year.
Average pay of disclosed executives at Clovis Oncology
Patrick J. Mahaffy, Chief Executive Officer, received $3.2M in total, which decreased by 53% compared to 2019. 62% of Mahaffy's compensation, or $2M, was in option awards. Mahaffy also received $492K in bonus, $721K in salary, as well as $22K in other compensation.
For fiscal year 2020, the median employee pay was $230,943 at Clovis Oncology. Therefore, the ratio of Patrick J. Mahaffy's pay to the median employee pay was 14 to one.
Lindsey Rolfe, Chief Medical Officer, received a compensation package of $1.4M, which decreased by 48% compared to previous year. 44% of the compensation package, or $613K, was in stock awards.
Gillian C. Ivers-Read, EVP and Chief Regulatory Officer, earned $1.4M in 2020, a 49% decrease compared to previous year.
Paul E. Gross, General Counsel, received $1.3M in 2020, which decreases by 63% compared to 2019.
Daniel W. Muehl, Chief Financial Officer, earned $1.3M in 2020, a 63% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 28, 2021.